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Abstract
Background: Medical masks are commonly used in health care settings to protect healthcare workers (HCWs) from
respiratory and other infections. Airborne respiratory pathogens may settle on the surface of used masks layers,
resulting in contamination. The main aim of this study was to study the presence of viruses on the surface of
medical masks.
Methods: Two pilot studies in laboratory and clinical settings were carried out to determine the areas of masks
likely to contain maximum viral particles. A laboratory study using a mannequin and fluorescent spray showed
maximum particles concentrated on upper right, middle and left sections of the medical masks. These findings
were confirmed through a small clinical study. The main study was then conducted in high-risk wards of three
selected hospitals in Beijing China. Participants (n = 148) were asked to wear medical masks for a shift (6–8 h) or as
long as they could tolerate. Used samples of medical masks were tested for presence of respiratory viruses in upper
sections of the medical masks, in line with the pilot studies.
Results: Overall virus positivity rate was 10.1% (15/148). Commonly isolated viruses from masks samples were
adenovirus (n = 7), bocavirus (n = 2), respiratory syncytial virus (n = 2) and influenza virus (n = 2). Virus positivity was
significantly higher in masks samples worn for > 6 h (14.1%, 14/99 versus 1.2%, 1/49, OR 7.9, 95% CI 1.01–61.99) and
in samples used by participants who examined > 25 patients per day (16.9%, 12/71 versus 3.9%, 3/77, OR 5.02, 95%
CI 1.35–18.60). Most of the participants (83.8%, 124/148) reported at least one problem associated with mask use.
Commonly reported problems were pressure on face (16.9%, 25/148), breathing difficulty (12.2%, 18/148),
discomfort (9.5% 14/148), trouble communicating with the patient (7.4%, 11/148) and headache (6.1%, 9/148).
Conclusion: Respiratory pathogens on the outer surface of the used medical masks may result in self-
contamination. The risk is higher with longer duration of mask use (> 6 h) and with higher rates of clinical contact.
Protocols on duration of mask use should specify a maximum time of continuous use, and should consider
guidance in high contact settings. Viruses were isolated from the upper sections of around 10% samples, but other
sections of masks may also be contaminated. HCWs should be aware of these risks in order to protect themselves
and people around them.
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Background
Infectious diseases are a continuing threat, with constant
emergence or re-emergence of serious diseases in vari-
ous parts of the world and healthcare workers (HCWs)
are particularly at-risk of exposure to index cases [1–4].
Various types of personal protective equipment (PPE)
are recommended and used by HCWs to protect from
infections, including medical masks, respirators, gloves,
gowns, goggles and face shield [5, 6]. In healthcare set-
tings, medical masks are used by HCWs to protect from
splashes and sprays of blood and body fluids, and by sick
individuals to prevent spread of respiratory infections to
others [7]. Reuse and extended use of masks are also
common in many parts of the world, particularly during
outbreaks and pandemics [8, 9]. Respiratory pathogens
may be present on used masks layers and lead to infec-
tion of the wearer [10]. In hospital settings, these patho-
gens may be generated from breathing, coughing or
sneezing patients or during aerosol generating medical
procedures [11]. Studies have shown that influenza virus
can remain airborne for 3 h after a patient has passed
through an emergency department [12]. While using
masks, or during long periods of time of re-using them,
these pathogens may cause infection through hand or
skin contamination, ingestion, or mucus membrane con-
tact [10].
Currently there are limited data on the presence of re-
spiratory pathogens on surface of PPE and other fomites
in hospital settings. Previous studies show that influenza
and respiratory syncytial virus (RSV) may survive on
outer surface of PPE [11–14]. A study showed that
influenza viruses may survive on hard surfaces for
24–48 h, on cloth up to 8–12 h and on hands for up
to 5 min [13]. A previous study in an Australian Neo-
natal Intensive Care Unit (NICU), respiratory syncyt-
ial virus (RSV) RNA was identified from 4% of dress
samples and 9% of environmental samples [14]. If
health departments do not provide clear guidance on
the use of masks in these situations, HCWs may con-
tinue using contaminated masks and may get infec-
tion [15]. The risk of self-contamination of HCWs is
influenced by the mask itself, its shape and proper-
ties, and the virus concentration on its surface. To
our knowledge, only one study examined the presence
of contamination on mask and various bacteria were
isolated from outer surface of medical masks [16].
The main aim of this study was to study the level of
contamination on the surface of medical masks.
Methods
Pilot studies
Medical masks were tested as per protocols developed
through two pilot studies in Sydney Australia.
Pilot study 1 (laboratory testing)
The aim of this pilot study was to identify areas of max-
imum virus concentration on the surface of masks. Med-
ical masks were donned on a simple mannequin in a
laboratory setting and fluorescent particles (UV Glow
powder) were sprayed front on and side on from a dis-
tance of approximately 1 m using a spray bottle. We per-
formed three experiments from the front and three
experiments from the sides of mannequin. UV light
was used to quantify the density of particles on mask
surface and to identify area of maximum concentra-
tion. In all three experiments, most particles were
concentrated on upper right, middle and left sections
of the masks (Figs. 1 and 2).
Pilot study 2 (clinical testing)
The second pilot study was conducted in two tertiary re-
ferral hospitals in Sydney Australia to develop testing
methodology. Twelve HCWs (doctors and nurses) from
the infectious diseases, respiratory/ chest wards and in-
tensive care unit (ICU) participated in the study. HCWs
were asked to wear medical masks for a shift (minimum
30min) used masks were tested in the Virology Research
Laboratory, University of New South Wales and
Prince of Wales Hospital Sydney Australia. If a respir-
ator was indicated due to airborne inflictions, HCWs
were excluded from the study and were allowed to
use a respirator.
Medical masks were divided into six sections as shown
in Fig. 3. Samples were taken from upper three sections
of masks i.e. 36 samples were tested in total (12 masks X
3 samples). The outer layer of the mask was removed
using sterile tweezers. The mask layer was placed into a
15ml falcon tube containing 700 μl of Phosphate buff-
ered saline and vortexed for 20 s. After 10 min incuba-
tion the mask was placed in a custom made filter tube
inside an eppendorf tube and centrifuged briefly. The fil-
trate was then transferred to 1.5 ml Eppendorf tube.
Total nucleic acid was extracted on the Kingfisher Flex
(Thermo Scientific) using the MagNA Pure Total Nu-
cleic Acid Isolation Kit (Roche) according to the manu-
facturer’s instructions. Presence of respiratory viruses
was detected using the Seegene Allplex™ Respiratory
Panel Assays 1,2,3 (Seegene).
Main study
The main study was conducted in respiratory wards and
fever clinics of three selected hospitals in Beijing China
from December 2017 to January 2018. Doctors and
nurses from selected wards were invited to participate in
the study. Participants include nursing and medical staff
aged > 18 years working full time in the ward who were
able to provide written and informed consent. Partici-
pants with pre-existing respiratory, medical illness or
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pregnancy were excluded. As we did not test the partici-
pants, detail history on respiratory symptoms was taken
to rule out contamination of masks by participants
themselves.
HCWs from the participating wards were asked to
wear medical masks for a shift (6–8 h), or as long as they
could tolerate the masks with no adverse event. Three
layered standard medical masks were used. If HCWs
used more than one mask during their shift, first sample
was collected and tested. Used medical masks were col-
lected at the end of the day and were stored immediately
in zip-lock bags. HCWs were advised to store masks in
in zip-lock bags while they take off the masks during
break time. All masks samples were labelled with partici-
pants’ ID and hospital ID. At the end of the study,
HCWs were asked to complete a short survey to collect
information on mask use in routine (type of mask used,
number of masks used and situations when masks were
normally used) and during the study period (wearing
time, number of patients seen, situations when masks
were used, aerosol generating procedures performed and
hand hygiene during donning and doffing). Partici-
pants reported “number of masks used” and “number
of patients seen” in absolute numbers. “Duration of
mask use” was recorded in hours as, < 1 h, 1 to 2 h, 2
to 4 h, 5 to 6 h, 7 to 8 h, > 8 h. “Situations when
masks were used” were categorized into: “used con-
tinuously”, “used continuously except during breaks”,
“used only during patients’ encounters” and “used
only high-risk patient encounters”.
Mask testing for the main study
Medical masks were tested in the Beijing CDC laboratory.
All masks were collected immediately after use in zip-lock
bags and kept at − 80 °C until testing. Pilot studies showed
that upper sections of masks were more contaminated (Figs.
1 and 2). The outer layers of upper right, middle and left
mask were separated with a same size, placed into separated
tubes containing 700μl PBS buffer (Gibco, USA), vortexed
for 1 min, and finally aliquoted 50 μl for viral testing. We
performed three tests on upper right, middle and upper left
sections of the masks on around a quarter mask sample
(26%) and performed one test on the remaining mask sam-
ples (74%). For one testing, outer layers of upper right, mid-
dle and left section of mask were separated and placed into
the same tube. Viral DNA/RNA was extracted using King-
Fisher Flex 96 viral DNA/RNA purification kit (Thermo
Fisher, USA) according to the manufacturer’s instructions.
The reverse-transcription polymerase chain reaction was per-
formed to amplify 15 viral target genes, including influenza
A/B virus, influenza A(H1N1) and A(H3N2), parainfluenza
viruses 1–4, rhinoviruses, bocavirus, human metapneumo-
virus, adenovirus, respiratory syncytial virus, coronaviruses
OC43, 229E, NL63 and HKU1 using a commercial multiplex
combined real-time PCR detection kit for Respiratory virus,
which is developed by “Jiangsu Uninovo Biological Technol-
ogy Co. Ltd.” in China.
Sample size
Currently there is very limited data on testing of masks
surface for presence of pathogens. In previous studies
Fig. 1 Fluorescent particles (UV Glow power) following spraying from 1m from the front of the mask
Fig. 2 Fluorescent particles (UV Glow powder) following spraying from 1m from the side of the mask
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influenza virus was detected on over 50% of the fomites
tested in community settings during influenza season
[17]. The rate is expected to be higher in the healthcare
setting and moreover other viruses will also be tested.
Assuming 25% higher positivity rate in the healthcare
setting, the required sample size would be 134 masks,
with 80% power and two-sided 5% significance level for
detecting a significant difference. Some HCWs might
not be able to provide mask samples, we aimed to re-
cruited 145 HCWs in total for this study.
Analysis
Descriptive analysis was conducted, and rates and fre-
quencies were calculated. Univariate analysis was per-
formed to identify the factors associated with mask
positivity. Logistic regression was used to calculate odds
ratio (OR) and 95% confidence intervals (CI) Data were
analyzed in SAS (SAS Institute Inc., USA) version 9.4.
Ethics and consent to participate
Ethics approval for pilot study was sought from South
Eastern Sydney Local Health District (SESLHD). Eth-
ics approval for the main study was sought from Hu-
man Research Ethics Committee UNSW (HC16703)
and IBR China. Written consent as obtained from all
participants.
Results
Of 36 samples in pilot testing, three samples were posi-
tive for human enterovirus. Two samples were positive
from outer sections of mask, while one sample was posi-
tive from middle section. No other viruses were detected
in mask samples.
A total of 158 participants were recruited from three
hospitals in the main study. Ten participants provided
more than one samples for the testing, so we excluded
these cases from analysis due to uncertainty around the
duration of mask use being tested. Most participants
were recruited from Hospital A (52%, 77/148), largely
from the respiratory ward 47.3%, 70/148). Around half
of the participants were doctors (45.9%, 68/148), and
majority were female (81.8%, 121/148). In routine clin-
ical practice, almost all participants (98.6%, 146/148) had
previously used disposable medical masks. Generally,
most of the participants had been using 1 or 2 medical
masks per day (90.6%, 134/148) and around two third
participant (68.2%, 101/148) had been using mask all the
time during the clinical work (Table 1).
During the study period, around 2/3 participants used
masks for > 6 h – “7–8 h” 80 participants (54.1%) and “> 8
h” 19 participants (12.8%). The remaining 1/3 used masks
for ≤6 h – “1–2 h” 1 participant (0.7%), “3–4 h” 8 partici-
pants (5.4%) and “5–6 h” 40 participants (27%). Most par-
ticipants (78.4%, 116/148) used masks either continuously
or continuously except breaks. The majority of partici-
pants (83.8%,124/148) reported at least one problem
Fig. 3 Sections of medical masks for testing
Table 1 Demographic data
Variables Number (n = 148) Percent
Hospital
Hospital A 77 52.0
Hospital B 26 17.6
Hospital C 45 30.4
Ward







≤ 30 year 41 27.7
31–40 years 68 45.9




Type of mask normally used in the hospital
Cloth re-usable facial masks 2 1.4
Disposable medical masks 146 98.6





When masks are normally used
All the time 101 68.2
When treating certain patients 47 32.8
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associated with masks use. Commonly reported problems
were pressure on face (16.9%, 25/148), breathing difficulty
(12.2%, 18/148), discomfort (9.5% 14/148), trouble com-
municating with the patient (7.4%, 11/148) and headache
(6.1%, 9/148). Majority of participants washed their hand
during donning (91.2%, 135/148) /doffing (88.5%, 131/
148) of medical masks and before (74.3%, 110/148) /after
(85.1%, 126/148) touching patients. During the study
period, 68% (101/148) participants used other PPE as well
– mostly gloves and hair covers.
Overall virus positivity rate was 10.1% (15/148) and
rates were similar after 1 testing on mask (10%, 11/110)
compared to three testing (10.5%, 4 /38) (OR 1.06, 95%
CI 0.32–3.55). Adenovirus was most commonly isolated
from the masks (n = 7), followed by bocavirus (n = 2),
RSV (n = 2) and influenza virus (n = 2) (Table 2).
Compared to the participants working in internal
medicine department, virus positivity rates were lower
among those working in respiratory (OR 0.04, 95% CI
0.01–0.34) and pediatric (OR 0.12, 95% CI 0.01–0.97)
departments. Virus positivity was significantly higher on
masks samples worn by participants who used masks for
> 6 h, compared to those who used mask for ≤6 h that
day (OR 7.9, 95% CI 1.01–61.99). Similarly, virus positiv-
ity was significantly higher on masks samples worn by
participants who examined > 25 patients per day, com-
pared to who examined ≤25 patients (OR 5.02, 95% CI
1.35–18.60). Virus positivity rates were also higher in
mask samples collected from males, participants who
used mask during encounters with high risk patients and
those who performed aerosol generating procedures
(AGPs), however the difference was not statistically sig-
nificant (Table 3).
Discussion
To our knowledge this is the first study examining the
presence of respiratory viruses on the outer surface of
used medical masks. One in ten masks were positive for
any virus which highlights the risk of self-contamination
to the wearer, particularly on doffing [18]. Reuse and ex-
tended use of masks are very common, particularly in
low income countries and during outbreaks and pandemics
when supplies are short, and demand is high [19, 20]. Staff
should be aware of the risk associated with the reuse and
extended use of masks and respiratory protective devices
and high clinical contact. Large scale studies should be con-
ducted to determine the contamination on other PPEs as
well and to quantify the risk of infection among HCWs.
Epidemics of a new infectious disease may be devastat-
ing due to global spread, disease burden and high case
fatality. PPE are generally considered lowest among in-
fection control hierarchy and recommended to be used
with other administrative and environmental control
measures [21]. However, masks, respirators and other
PPE are important during initial phase of outbreak and
pandemic when drugs and vaccine are not available [22].
PPE can easily get contaminated during clinical care of
sick patients which may result in an increased risk of in-
fection in wearer [18]. Many simulation studies have also
shown presence of particles on the potential surface of
PPE and associated risk of self-contamination during
doffing of PPE [5, 22–24]. In this study we only tested
the presence of viruses on the medical masks. Overall
virus positivity rate in this was 10.1% (15/148) and
adenovirus was isolated from 7 mask samples while
bocavirus, RSV and influenza viruses were isolated from
2 samples each. Prospero et al. conducted a study in
dental settings and estimated the bacterial contamin-
ation on surface of masks used by dentist, lamps, areas
near spittoons, and mobile trays. Sterile nitrocellulose
filters were applied on these surfaces to isolate patho-
gens. Highest levels of bacterial contamination
(Streptococcus species 42%, Staphylococcus species
41%, and gram-negative bacteria 17%) were recorded
on the external surface of masks wore by dentist [16].
Large scale studies should be conducted to examine
presence of various pathogens on the surface of masks
and other PPE.
In this study, the risk of mask contamination was asso-
ciated with duration of masks use and number of pa-
tients seen. Currently there is no standard duration for
the time period that facemasks and respirators can safely
Table 2 Pathogens isolated from outer surface of masks
Viruses Positive in one test (Total tests 110) Positive in three tests & sample location (Total test 38)
Adenovirusa 6 1 middle section of mask
Bocavirusa 2 0
Human metapneumovirusa 0 1 right section of mask
Influenza B & type 4 parainfluenza virusb 1 0
Influenza H1N1 & influenza Bc 1 0
Respiratory syncytial virusa 1 1 middle section of mask
Type 2 parainfluenza virusa 0 1 right section of mask
Total positive (Positivity rate) 11 (9.4%) 4 (9.8%)
a Isolated from internal medicine ward, b isolated from pediatric ward c isolated from respiratory ward
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be used. Theoretically, there may be a risk of infection
in wearer if contaminated masks are used for prolonged
time. Currently there are no data around risk associated
with reuse and extended used of masks and other PPE.
One study showed that influenza virus may survive on
mask surface and maintained infectivity for at least 8 h
[25]. Our study showed very low infection among HCWs
who used masks for ≤6 h. High virus positivity on masks
samples worn by HCWs who examined > 25 patients,
may be due to more frequent clinical contact with in-
fective cases and transfer of more pathogens from pa-
tients to mask surface. Virus positivity rates were also
higher in those working in internal medicine department
compared to respiratory and pediatric departments. The
reason of high virus positivity in internal medicine de-
partment is not clear, but this may be due to using
Table 3 Factors associated with virus positivity on masks surface
Variables Positive for any virus Odds ratio (OR) (95% CI)
Number Percent
Hospital
Hospital A 12/77 15.6 Refa
Hospital B 1/26 3.8 0.22 (0.03–1.75)
Hospital C 2/45 4.4 0.25 (0.05–1.18)
Ward
Internal medicine department 13/52 25 Ref
Respiratory department 1/70 1.4 0.04 (0.01–0.34)d
Pediatrics department 1/26 3.8 0.12 (0.01–0.97)d
Gender
Male 4/27 14.8 Ref
Female 11/121 9.1 0.57 (0.16–1.97)
Position
Doctor 7/68 10.3 Ref
Nurse 8/80 10 0.97 (0.33–2.82)
Age
≤ 30 years 5/41 12.2 Ref
31–40 years 5/68 7.4 0.57 (0.15–2.11)
≥ 41 years 5/39 12.8 1.06 (0.28–3.98)
Mask use time during the study
≤ 6 h 1/49 2 Ref
> 6 h 14/99 14.1 7.9 (1.01–61.99)d
Patients’ seen
≤ 25 cases 3/77 3.9 Ref
> 25 cases 12/71 16.9 5.02 (1.35–18.60)d
How medical masks were used
Used continuously 4/28 14.3 Ref
Used continuously except breaksb 9/88 10.2 0.65 (0.19–2.22)
Used only during patients encounters 0/26 0 0.10 (0.01–2.12)
Used only high-risk patient encounters 2/6 33.3 3.02 (0.43–21.44)
Preformed AGPs c during the study
No 7/95 7.4 Ref
Yes 8/53 15.1 2.24 (0.76–6.55)
Hand wash
No 2/13 15.4 Ref
Yes 13/135 9.6 0.59 (0.12–2.94)
a Reference b lunch, tea and toilet c aerosol generating procedures dSignificant results
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varying infection control policies and practices. High risk
perception and more infection control measures may re-
sult in low virus positivity in in respiratory and pediatric
departments. However, the sample sizes and number of
positive results were too low to make meaningful com-
parisons between departments. There is a need for more
research to define the exact threshold of safe duration,
and to develop a comprehensive policy on the use of
masks in hospital settings and protocols should specify a
maximum time of continuous use and should consider
guidance in high contact settings.
We also aimed to identify the area on the mask surface
with maximum respiratory virus concentration. Labora-
tory based pilot study showed maximum fluorescent
contamination on upper sections of the masks, which is
also the likely area to be touched on removal. Of the
three positive tests in hospital-based pilot study, two
samples were positive from outer sections of mask, while
one sample was positive from middle section. In the
main study we were able to check the location of con-
tamination on a quarter of mask samples. Of the 38
mask samples, one or more viruses were isolated from
four (10.5%) samples – two from middle section of
masks and two from right section of the masks. This
presents a large area of potential contamination which
place HCW at risk when removing a mask. These data
may assist in developing policies on for doffing of masks
after encounter with infective cases. As a general rule,
HCWs should not reuse masks, should restrict use to
less than 6 h and avoid touching the outer surface of
mask during doffing, and practice hand hygiene after
removal.
There are limitations of this study. Due to funding
constraints we tested selected masks samples. We per-
formed three tests on a sub-sample (26%) to identify the
area of maximum concentration. Moreover, we just
tested upper three sections of medical masks based on
the first pilot study, while lower three sections should
also be tested. Then we tested only outer layer of masks
and did not check filtering layer and inner layer due to
funding constraints. Ideally all sections and layers of
masks should be tested. We collected detail history from
the participants to rule out any existing respiratory ill-
ness. Although none of the participant had a respiratory
or a medical illness, it is not possible to determine
whether viruses isolated from the masks surface were
from exogenous or endogenous source. For example,
adenovirus was most commonly identified in this study
and is associated with mild or no respiratory illnesses.
Ideally participants should also be swabbed to rule out
infections, and the inside surface should also be tested.
However, given the large variations of infection probabil-
ity in different types of wards, it is unlikely that all vi-
ruses came from the background infection. To overcome
this limitation, detailed history on respiratory symptoms
was taken to rule out contamination of masks by clinic-
ally ill participants themselves. Moreover, we only exam-
ined viruses on the masks, while bacteria and other
pathogens may also be present [16]. Mask use was not
monitored, and self-reported compliance was recorded.
Previous studies show that self-reported compliance is
generally reported to be higher compared to the actual
compliance [26, 27]. We also did not document the
method of mask removal, nor the number of times the
HCW touched the mask.
Conclusion
To maintain the functionality and capacity of the health
care workforce during outbreaks or pandemics of emer-
ging infections, HCWs need to be protected. This study
provides new data, which will help developing policies
for safe workplace environment. The study shows that
the prolonged use of medical masks (> 6 h) and frequent
clinical contact in healthcare setting increase the risk to
health workers through contaminated PPE. Protocols on
duration of mask use should specify a maximum time of
continuous use.
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